Burkhart Erin — SEC Form 4 filings
SEC reporting owner CIK 1927648. 10 Form 4 filings on record with FilingPulse; latest filed 2026-03-12.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-19 to 2026-03-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 7,425 shares, $560,449 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 2,286 shares @ $90.00 ($205,740) in BIOMARIN PHARMACEUTICAL INC, filed 2024-04-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | 8 | — | 5 legs · 7,425 sh · $560,449 | 8 |
| GILEAD SCIENCES, INC. (GILD) | SVP, Controllership | 2 | — | — | 3 |
Form 4 filings — Burkhart Erin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-12 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 2,355 (derivative) · Grant/award (A): 5,455 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 8,890 (derivative) | EDGAR |
| 2025-05-20 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 996 @ $59.27 · Sale (S): 1,786 @ $59.31 | EDGAR |
| 2025-03-20 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 1,295 @ $71.52 | EDGAR |
| 2025-03-18 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 823 @ $69.44 · Grant/award (A): 5,970 @ $0 · Grant/award (A): 9,230 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 1,344 @ $68.38 | EDGAR |
| 2024-08-15 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 714 @ $90 | EDGAR |
| 2024-05-20 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 993 @ $76.97 | EDGAR |
| 2024-04-12 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 2,286 @ $90 | EDGAR |
| 2024-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 4,720 @ $0 · Tax withholding (F): 372 @ $83.87 · Grant/award (A): 7,050 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1927648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →